Back to search

Article

Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast Cancer

2025-09-15

Abstract excerpt

<h4>Background</h4> We investigated the impact of gender-affirming testosterone therapy (TT) on breast cancer (BC) risk and tumor progression. <h4>Materials and methods</h4> We leveraged a large human breast tissue dataset (n=417) to assess TT and terminal duct lobular unit (TDLU) involution, complemented with tissue markers (ER, PR, AR, and Ki67; n =24) and transcriptome profiling ( n =8). Preclinical models as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f5ca30ed-6d1f-5070-a0e6-b0ab18d8a4b5
DOI
10.1101/2025.09.15.25335324
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast CancerDOI 10.1101/2025.09.15.25335324
Select a neighboring publication to make it the new centre.